Baker McKenzie advised CSL in its strategic partnership with Thermo Fisher

CSL enters partnership with Thermo Fisher Scientific, a global biotechnology company with a dynamic portfolio of life-saving medicines. The strategic partnership was created to help meet the increasing demand for biologic therapies while also accelerating CSL’s broader manufacturing objectives. Through a long-term lease agreement with CSL, Thermo Fisher will operate a new state-of-the-art biologics manufacturing facility in Lengnau, Switzerland, when construction is completed in 2021.

The team

Baker McKenzie has advised CSL Limited in all legal matters on its partnership with Thermo Fisher Scientific. The Zurich team consisted of partners Alexander Wyss (pictured left), Peter Reinert (pictured centre), Boris Wenger (picture right), associates Johanna Moesch, Michael Zeller, Julia Schieber and Roger Thomi.